SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) of $4.24M in Q1 FY2026
Q1 FY2026 property, plant & equipment (net) was $4.24M.
Context
- Property, plant & equipment (net) amounted to 1.6% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 3.89M USD
- Year-over-year change
- —
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.89M | — |
Property, Plant & Equipment (Net) vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Property, plant & equipment (net) amounts to 1.6% of total assets for SGP, versus a peer median of 7.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $5.28B USD | +2.6% | +5.7% | 16.8% | |
| Jun 2026 | $1.8B USD | +7.1% | +7.5% | 13.0% | |
| Jun 2026 | $181.58M USD | -1.5% | +3.4% | 19.7% | |
| Apr 2026 | $100.31M USD | -5.4% | +8.1% | 22.2% | |
| Mar 2026 | $24.92M USD | +50.0% | +10.8% | 3.4% | |
| Mar 2026 | $22.99M USD | -2.1% | +17.8% | 7.6% | |
| Mar 2026 | $19.78M USD | -33.1% | +39.8% | 6.9% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $4.24M USD | — | — | 1.6% |
| Mar 2026 | CHF 2.86M CHF | +80.7% | +38.8% | 1.2% | |
| Mar 2026 | $2.82M USD | +22.5% | -13.7% | 2.6% | |
| Peer median (excluding SGP) | — | +2.6% | +8.1% | 7.6% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.